Jean S.-S.Tsai M.-H.Chen W.-C.Ho S.-J.Wu M.-H.PO-REN HSUEH2020-12-182020-12-1820090924-8579https://scholars.lib.ntu.edu.tw/handle/123456789/528699[SDGs]SDG3ampicillin; ceftazidime; cephalosporin; chloramphenicol; ciprofloxacin; cotrimoxazole; doxycycline; drotrecogin; imipenem; isepamicin; levofloxacin; macrolide; moxifloxacin; piperacillin plus tazobactam; quinoline derived antiinfective agent; tetracycline; tigecycline; aged; anamnesis; antibiotic resistance; artificial ventilation; auscultation; blood culture; case report; cholera; choleraesuis bacteraemia; community acquired pneumonia; human; laboratory test; Legionella pneumophila; letter; male; mortality; physical examination; priority journal; Salmonella enterica; serotype; thorax radiography; Aged; Anti-Bacterial Agents; Bacteremia; Community-Acquired Infections; Drug Resistance, Bacterial; Fatal Outcome; Fluoroquinolones; Humans; Legionella pneumophila; Legionnaires' Disease; Male; Radiography, Thoracic; Salmonella; Salmonella Infectionsletter10.1016/j.ijantimicag.2008.08.006189930352-s2.0-58149186648